Interobserver Variability in Applying American Society of Echocardiography/European Association of Cardiovascular Imaging 2016 Guidelines for Estimation of Left Ventricular Filling Pressure.


Journal

Circulation. Cardiovascular imaging
ISSN: 1942-0080
Titre abrégé: Circ Cardiovasc Imaging
Pays: United States
ID NLM: 101479935

Informations de publication

Date de publication:
12 2019
Historique:
entrez: 12 1 2019
pubmed: 12 1 2019
medline: 29 10 2019
Statut: ppublish

Résumé

Assessment of left ventricular (LV) filling pressure is among the important components of a comprehensive echocardiographic report. Previous studies noted wide limits of agreement using 2009 American Society of Echocardiography/European Association of Echocardiography guidelines, but reproducibility of 2016 guidelines update in estimating LV filling pressure is unknown. Echocardiographic and hemodynamic data were obtained from 50 patients undergoing cardiac catheterization for clinical indications. Clinical and echocardiographic findings but not invasive hemodynamics were provided to 4 groups of observers, including experienced echocardiographers and cardiology fellows. Invasively acquired LV filling pressure was the gold standard. In group I of 8 experienced echocardiographers from the guidelines writing committee, sensitivity for elevated LV filling pressure was 92% for all observers, and specificity was 93±6%. Fleiss κ-value for the agreement in group I was 0.80. In group II of 4 fellows in training, sensitivity was 91±2%, and specificity was 95±2%. Fleiss κ-value for the agreement in group II was 0.94. In group III of 9 experienced echocardiographers who had not participated in drafting the guidelines, sensitivity was 88±5%, and specificity was 91±7%. Fleiss κ-value for the agreement in group III was 0.76. In group IV of 7 other fellows, sensitivity was 91±3%, and specificity was 92±5%. Fleiss κ-value for the agreement in group IV was 0.89. There is a good level of agreement and accuracy in the estimation of LV filling pressure using the American Society of Echocardiography/European Association of Cardiovascular Imaging 2016 recommendations update, irrespective of the experience level of the observer.

Sections du résumé

BACKGROUND
Assessment of left ventricular (LV) filling pressure is among the important components of a comprehensive echocardiographic report. Previous studies noted wide limits of agreement using 2009 American Society of Echocardiography/European Association of Echocardiography guidelines, but reproducibility of 2016 guidelines update in estimating LV filling pressure is unknown.
METHODS
Echocardiographic and hemodynamic data were obtained from 50 patients undergoing cardiac catheterization for clinical indications. Clinical and echocardiographic findings but not invasive hemodynamics were provided to 4 groups of observers, including experienced echocardiographers and cardiology fellows. Invasively acquired LV filling pressure was the gold standard.
RESULTS
In group I of 8 experienced echocardiographers from the guidelines writing committee, sensitivity for elevated LV filling pressure was 92% for all observers, and specificity was 93±6%. Fleiss κ-value for the agreement in group I was 0.80. In group II of 4 fellows in training, sensitivity was 91±2%, and specificity was 95±2%. Fleiss κ-value for the agreement in group II was 0.94. In group III of 9 experienced echocardiographers who had not participated in drafting the guidelines, sensitivity was 88±5%, and specificity was 91±7%. Fleiss κ-value for the agreement in group III was 0.76. In group IV of 7 other fellows, sensitivity was 91±3%, and specificity was 92±5%. Fleiss κ-value for the agreement in group IV was 0.89.
CONCLUSIONS
There is a good level of agreement and accuracy in the estimation of LV filling pressure using the American Society of Echocardiography/European Association of Cardiovascular Imaging 2016 recommendations update, irrespective of the experience level of the observer.

Identifiants

pubmed: 30632389
doi: 10.1161/CIRCIMAGING.118.008122
doi:

Types de publication

Comparative Study Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

e008122

Auteurs

Sherif F Nagueh (SF)

Methodist DeBakey Heart and Vascular Center, Center for Outcomes Research, Houston Methodist Research Institute, TX (S.F.N., M.A.C.-p., K.C.E.t., J.X.).

Theodore P Abraham (TP)

Department of Medicine, University of Massachusetts Medical School, Worcester (G.P.A., S.R.S.).
Division of Cardiology, University of California at San Francisco (T.P.A., A.B.).

Jeroen J Bax (JJ)

Department of Cardiology, Leiden University Medical Center, the Netherlands (J.J.B., V.D., G. Dolci).

Carmen Beladan (C)

University of Medicine and Pharmacy "Carol Davila," Euroecolab, Institute of Cardiovascular Diseases, Bucharest, Romania (C.B., B.A.P.).

Alyssa Browning (A)

Division of Cardiology, University of California at San Francisco (T.P.A., A.B.).

Mohammed A Chamsi-Pasha (MA)

Methodist DeBakey Heart and Vascular Center, Center for Outcomes Research, Houston Methodist Research Institute, TX (S.F.N., M.A.C.-p., K.C.E.t., J.X.).

Victoria Delgado (V)

Department of Cardiology, Leiden University Medical Center, the Netherlands (J.J.B., V.D., G. Dolci).

Genevieve Derumeaux (G)

Physiology Department, DHU Ageing-Thorax-Vessel-Blood, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France (G. Derumeaux, L.E., M.P.).

Giulia Dolci (G)

Department of Cardiology, Leiden University Medical Center, the Netherlands (J.J.B., V.D., G. Dolci).

Erwan Donal (E)

Service de Cardiologie et Maladies Vasculaires, LTSI INSERM 1099, Universite Rennes-1, CHU Rennes, France (E.D., A.H.).

Thor Edvardsen (T)

University of Oslo, Norway (T.E., O.A.S.).

Kinan Carlos El Tallawi (KC)

Methodist DeBakey Heart and Vascular Center, Center for Outcomes Research, Houston Methodist Research Institute, TX (S.F.N., M.A.C.-p., K.C.E.t., J.X.).

Laura Ernande (L)

Physiology Department, DHU Ageing-Thorax-Vessel-Blood, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France (G. Derumeaux, L.E., M.P.).

Roberta Esposito (R)

Department of Advanced Biomedical Sciences, Federico II University Hospital, Naples, Italy (R.E., M.G.).

Frank A Flachskampf (FA)

Department of Medical Sciences, Uppsala University, Clinical Physiology and Cardiology, Uppsala, Sweden (F.A.F.).

Maurizio Galderisi (M)

Department of Advanced Biomedical Sciences, Federico II University Hospital, Naples, Italy (R.E., M.G.).

James Gentry (J)

Cleveland Clinic, OH (J.G., S.C.H., A.L.K.).

Steven A Goldstein (SA)

Department of Cardiology, MedStar Heart and Vascular Institute, Washington, DC (S.A.G., R.Z.M.).

Serge C Harb (SC)

Cleveland Clinic, OH (J.G., S.C.H., A.L.K.).

Arnaud Hubert (A)

Service de Cardiologie et Maladies Vasculaires, LTSI INSERM 1099, Universite Rennes-1, CHU Rennes, France (E.D., A.H.).

Judy Hung (J)

Division of Cardiology, Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston (J.H.).

Allan L Klein (AL)

Cleveland Clinic, OH (J.G., S.C.H., A.L.K.).

Patrizio Lancellotti (P)

University of Liège Hospital, Belgium (P.L.).

Redah Z Mahmood (RZ)

Department of Cardiology, MedStar Heart and Vascular Institute, Washington, DC (S.A.G., R.Z.M.).

Paolo Marino (P)

Universita Piemonte Orientale, Novara, Italy (P.M.).

Bogdan A Popescu (BA)

University of Medicine and Pharmacy "Carol Davila," Euroecolab, Institute of Cardiovascular Diseases, Bucharest, Romania (C.B., B.A.P.).

Martina Previato (M)

Physiology Department, DHU Ageing-Thorax-Vessel-Blood, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France (G. Derumeaux, L.E., M.P.).

Saket R Sanghai (SR)

Department of Medicine, University of Massachusetts Medical School, Worcester (G.P.A., S.R.S.).

Otto A Smiseth (OA)

University of Oslo, Norway (T.E., O.A.S.).

Jiaqiong Xu (J)

Methodist DeBakey Heart and Vascular Center, Center for Outcomes Research, Houston Methodist Research Institute, TX (S.F.N., M.A.C.-p., K.C.E.t., J.X.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH